STI Stock Trade Intelligence
CBL

CONTROL BIONICS LIMITED

Health Care · ASX:CBL
$0.0560
▼ -1.75%
Market cap
$30M
Turnover
$7,617
Last price
$0.0560
Day change
-1.75%
Announcements
12
Range, past year
Open 0.034 · Low 0.026 · Now 0.056 · High 0.095
Open CBL in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.

CBL momentum and trend analysis

Our analysis
Independent analysis generated by Stock Trade Intelligence as at 2026-09-28.
Momentum quality
23/100
Wyckoff phase
Downtrend2d
Trend stage
Breakdown
1 Day
-1.8%
1 Week
-8.2%
1 Month
-3.4%
1 Year
+64.7%
RSI
39
Avg daily range
4.3%

CONTROL BIONICS LIMITED scores 23 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Breakdown.

On the Wyckoff cycle it sits in Downtrend, where it has been for 2 trading days. The weekly timeframe reads Downtrend, which agrees with the daily view.

Against the wider market it is currently underperforming and the institutional accumulation signal reads low.

Points to watch
  • 60d drawdown -25.3%
  • Thin liquidity
  • Risk rating: Very High
  • Composite downside risk elevated
Browse the whole market by signal:
ASX stocks in Wyckoff accumulationASX momentum stocks by trend qualityASX stocks breaking outASX stocks near 52-week highs

CBL announcements

Recent price-sensitive releases.
  • 2026-08-28 Preliminary Final Report Preliminary Final Report
  • 2026-08-27 Medicare Billing Code Secured for NextLevel Speech Devices Progress Report
  • 2026-08-25 NeuroStrip secures MHRA registration Progress Report
  • 2026-08-04 US FDA Registration and Device Listing for NeuroStrip Progress Report
  • 2026-07-31 Commercial momentum builds across both platform pillars Progress Report
  • 2026-07-31 Quarterly Activities/Appendix 4C Cash Flow Report Commitments Test Entity - Fourth Quarter Activity Report | Commitments Test Entity - Fourth Quarter Cashflow Report
  • 2026-06-25 Completion of Placement
Get the daily briefing The day's price-sensitive announcements, ranked by what actually moved, with our own momentum and cycle read on each.